Budapest, Hungary

Gaborne Forrai

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Richter Gedeon Vegyeszeti Gyar Rt. Active years: 2003.


% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gaborne Forrai: Innovator in Pharmaceutical Compositions

Introduction

Gaborne Forrai is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of peptic ulcers. His innovative approach has led to the development of a unique composition that utilizes zinc hyaluronate as an active ingredient.

Latest Patents

Gaborne Forrai holds a patent for the "Use of zinc hyaluronate against peptic ulcer." This invention relates to pharmaceutical compositions designed to combat peptic ulcers. The compositions contain zinc hyaluronate, which has a molecular weight ranging from 500,000 to 1,200,000 daltons. This innovative method of treatment offers a new avenue for addressing this common medical condition.

Career Highlights

Forrai is associated with Richter Gedeon Vegyeszeti Gyar Rt., a prominent pharmaceutical company in Hungary. His work at this institution has allowed him to focus on research and development in the pharmaceutical sector, contributing to advancements in medical treatments.

Collaborations

Gaborne Forrai has collaborated with notable colleagues, including Janos Illes and Judit Matuz. Their combined expertise has fostered a productive environment for innovation and development in their respective fields.

Conclusion

Gaborne Forrai's contributions to pharmaceutical compositions highlight the importance of innovation in medical treatments. His work not only addresses peptic ulcers but also exemplifies the potential of collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…